# Myxedema Coma as the Initial Presentation of Undiagnosed Hypothyroidism: A Rare but Reversible Emergency

**Authors:** Rabia Mansoor, Maheen Iqbal, Tushaar Kakkar, Aymen Bader, Taha Elsahy

PMC · DOI: 10.7759/cureus.98621 · 2025-12-07

## TL;DR

A 77-year-old man with multiple health issues was diagnosed with myxedema coma, a rare and severe form of hypothyroidism, which was his first sign of the condition.

## Contribution

This case highlights myxedema coma as a rare initial presentation of undiagnosed hypothyroidism in a patient with complex comorbidities.

## Key findings

- The patient presented with severe hypothyroidism and features of myxedema coma despite no prior diagnosis.
- Treatment with thyroid hormone replacement and supportive care led to rapid improvement in consciousness.
- The case underscores the diagnostic challenges in patients with overlapping medical conditions.

## Abstract

Myxedema coma is a rare, life-threatening endocrine emergency representing the extreme manifestation of untreated hypothyroidism. It usually presents with nonspecific symptoms such as confusion, hypothermia, and bradycardia, which can lead to delayed recognition, particularly in elderly patients with multiple comorbidities. We report the case of a 77-year-old man with hypertension, stage 4 chronic kidney disease, anemia of chronic disease, myeloma, and prostate cancer who presented with reduced consciousness following a period of increasing lethargy and confusion. On arrival, he was hypotensive and hypothermic with a Glasgow Coma Scale (GCS) score of 8/15 and extensive lower limb edema, extending up to the abdomen. Laboratory investigations revealed severe hypothyroidism (thyroid-stimulating hormone (TSH) >99.9 mU/L; free thyroxine (T4) 8 pmol/L) and mild infection. A diagnosis of myxedema coma was made, and he was treated with intravenous hydrocortisone, nasogastric levothyroxine (later addition of intravenous liothyronine after discussion with the endocrinology team), antibiotics, and supportive measures, including cautious rewarming and fluid resuscitation. His level of consciousness improved within 48 hours, and thyroid function gradually normalized. The case illustrates how myxedema coma may be the first manifestation of previously undiagnosed hypothyroidism and highlights the diagnostic challenge posed by overlapping comorbidities.

## Linked entities

- **Chemicals:** hydrocortisone (PubChem CID 5754), levothyroxine (PubChem CID 5819), liothyronine (PubChem CID 5920)
- **Diseases:** hypothyroidism (MONDO:0005420), myxedema coma (MONDO:1010100), chronic kidney disease (MONDO:0005300), anemia of chronic disease (MONDO:0020725), myeloma (MONDO:0009693), prostate cancer (MONDO:0005159)

## Full-text entities

- **Diseases:** Myxedema Coma (MESH:D009230), Hypothyroidism (MESH:D007037), confusion (MESH:D003221), infection (MESH:D007239), edema (MESH:D004487), hypertension (MESH:D006973), bradycardia (MESH:D001919), hypotensive (MESH:D007022), lethargy (MESH:D053609), anemia of chronic disease (MESH:D002908), hypothermia (MESH:D007035), myeloma (MESH:D009101), Coma (MESH:D003128), prostate cancer (MESH:D011471), stage 4 chronic kidney disease (MESH:D051436)
- **Chemicals:** T4 (MESH:D013974), hydrocortisone (MESH:D006854), liothyronine (MESH:D014284)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12776204/full.md

---
Source: https://tomesphere.com/paper/PMC12776204